19NOVEMBER 2026automotive and volume manufacturing environments. SAV focuses on identifying applications where faster-curing formulations can substantially reduce bonding time without sacrificing the required performance."Our broader portfolio reflects the same application-led thinking. Alongside cyanoacrylates, SAV is developing and supplying anaerobic adhesives, UV light-cure solutions and products for specialized industrial requirements. Its portfolio also addresses different materials and operating conditions rather than forcing one formulation across multiple applications," shares Shain.R&D Built Around Problems the Market Actually HasProduct development at SAV Chemicals starts in the market rather than the laboratory. Customer observations and application challenges are taken back into R&D, where formulations are developed against identifiable requirements."The company assigns 30­40 percent of its business priority to R&D and innovation, recognizing that chemical innovation requires both patience and commercial discipline. A formulation can take one or two years to develop and validate, and not every technically successful formulation necessarily finds a viable market," shares Shain. This is where SAV benefits from its relationship with Cartell Chemical and the wider international ecosystem. Cartell brings around three decades of experience in cyanoacrylate technology, while SAV's access to teams in Taiwan and the UK facilitates exchange of formulation expertise, manufacturing practices, packaging knowledge and product-development experience.Indian employees have been sent to Taiwan for technical training, while specialists from Taiwan have travelled to India to train local teams. Rather than simply importing technology, the objective is to develop people capable of adapting that knowledge to Indian conditions.This R&D depth is increasingly being directed toward specialized products, including low-odor, low-blooming and light-curing adhesive technologies. Such development allows SAV to move beyond conventional bonding applications into markets where aesthetics, precision, controlled curing and application environment matter equally.Quality for Applications Where Failure Is Not an OptionAs adhesives move into medical devices, drinking-water systems and other controlled applications, performance alone is insufficient. Regulatory qualification and repeatable manufacturing become fundamental to market access.SAV Chemicals consequently emphasizes international testing and application-specific compliance. Singh points to certifications such as NSF requirements for relevant food and drinking-water applications and the ISO 10993 series associated with biological evaluation in medical-device contexts as examples of the standards that specialized adhesive manufacturers must understand.The company's own portfolio now includes medical device adhesives alongside industrial, consumer, anaerobic, UV light-cure and cosmetic adhesive categories, illustrating its movement toward technically differentiated segments.Equally important is manufacturing control. SAV emphasizes purity, formulation consistency and ethical manufacturing rather than diluting specifications to compete purely on price. In a market where procurement decisions can often be commercially driven, the company sees sustained performance as the stronger route to long-term customer retention."This approach is translating into business momentum. SAV Chemicals reported approximately 40 percent revenue growth in the previous year, according to the company. Independently available corporate data similarly records FY2025 revenue of Rs26.22 crore and 42 percent year-on-year growth, reinforcing the scale of the company's recent expansion," mentions Shain.The Next Bond: New Technologies, More LocalizationSAV Chemicals is now preparing for a larger manufacturing and innovation chapter. The newly acquired approximately 70,000 sq. ft. expansion area provides physical capacity for future development, while its product roadmap is centered on technologies that can open new applications rather than simply increasing the number of SKUs.Low-odor and low-blooming formulations, light-curing technologies and other advanced adhesive systems are among the areas receiving attention. The company intends to introduce products that remain limited or unavailable in the domestic market while gradually localizing additional technologies currently sourced internationally.Employee development will remain equally central. SAV plans to continue cross-border technical training and knowledge transfer between India, Taiwan and the UK, strengthening the domestic team's ability to formulate, manufacture and support increasingly sophisticated adhesive systems.Following its recent growth, the company is targeting significantly greater scale over the next two years. Yet its ambition extends beyond revenue. SAV wants to contribute to an Indian adhesives ecosystem where domestic manufacturing is supported by stronger technical understanding, international-quality processes and application-driven innovation.For SAV Chemicals, the next phase is not simply about making more adhesive. It is about ensuring that more of the technology, formulation expertise and value behind that adhesive is created in India.
< Page 9 | Page 11 >